Showing 1 - 5 results of 5 for search 'Witold Prejzner', query time: 0.03s Refine Results
  1. 1
    Quality of life in chronic myeloid leukaemia patients after haematopoietic cell transplantation pretreated with second-generation tyrosine kinase inhibitors

    Quality of life in chronic myeloid leukaemia patients after haematopoietic cell transplantation pretreated with second-generation tyrosine kinase inhibitors by Agnieszka Piekarska, Lidia Gil, Karolina Jakitowicz, Witold Prejzner, Mieczysław Komarnicki, Andrzej Hellmann

    Published 2016-12-01
    Get full text
    Article
  2. 2
    The role of daratumumab in relapsed/refractory CD38 positive acute leukemias—case report on three cases with a literature review

    The role of daratumumab in relapsed/refractory CD38 positive acute leukemias—case report on three cases with a literature review by Witold Prejzner, Oliwia Piekoś, Karolina Bełdzińska, Alicja Sadowska-Klasa, Ewa Zarzycka, Maria Bieniaszewska, Krzysztof Lewandowski, Jan Maciej Zaucha

    Published 2023-10-01
    Get full text
    Article
  3. 3
    Impact of First- and Second-Generation Tyrosine Kinase Inhibitors on the Development of Graft-Versus-Host Disease in Individuals with Chronic Myeloid Leukemia: A Retrospective Analysis on Behalf of the Polish Adult Leukemia Group

    Impact of First- and Second-Generation Tyrosine Kinase Inhibitors on the Development of Graft-Versus-Host Disease in Individuals with Chronic Myeloid Leukemia: A Retrospective Anal... by Ugo Giordano, Agnieszka Piekarska, Witold Prejzner, Lidia Gil, Jan Maciej Zaucha, Joanna Kujawska, Zuzanna Dybko, Krzysztof Dudek, Sebastian Giebel, Jarosław Dybko

    Published 2025-01-01
    Get full text
    Article
  4. 4
    Impact of genetic polymorphisms of drug transporters ABCB1 and ABCG2 and regulators of xenobiotic transport and metabolism PXR and CAR on clinical efficacy of dasatinib in chronic myeloid leukemia

    Impact of genetic polymorphisms of drug transporters ABCB1 and ABCG2 and regulators of xenobiotic transport and metabolism PXR and CAR on clinical efficacy of dasatinib in chronic... by Anna Marta Madejczyk, Federico Canzian, Joanna Góra-Tybor, Daniele Campa, Tomasz Sacha, Dorota Link-Lenczowska, Izabela Florek, Witold Prejzner, M. Całbecka, M. Rymko, M. Dudziński, Magdalena Julita Orzechowska, Krzysztof Jamroziak

    Published 2022-09-01
    Get full text
    Article
  5. 5
    High Level of CD8<sup>+</sup>PD-1<sup>+</sup> Cells in Patients with Chronic Myeloid Leukemia Who Experienced Loss of MMR after Imatinib Discontinuation

    High Level of CD8<sup>+</sup>PD-1<sup>+</sup> Cells in Patients with Chronic Myeloid Leukemia Who Experienced Loss of MMR after Imatinib Discontinuation by Paulina Kwaśnik, Joanna Zaleska, Dorota Link-Lenczowska, Magdalena Zawada, Hubert Wysogląd, Bogdan Ochrem, Grażyna Bober, Ewa Wasilewska, Iwona Hus, Monika Szarejko, Witold Prejzner, Olga Grzybowska-Izydorczyk, Agnieszka Klonowska-Szymczyk, Ewa Mędraś, Michał Kiełbus, Tomasz Sacha, Krzysztof Giannopoulos

    Published 2024-04-01
    Get full text
    Article

Search Tools: